![\"Can](\"https:\/\/themedicaltribune.com\/\/en\/wp-content\/uploads\/shared\/mri-2813909_640.jpg\")
<\/p>\n<\/p>\n
Metabolism-related liver diseases affect nearly one in three adults worldwide. These conditions, often associated with obesity or type 2 diabetes, can progress to serious complications such as cirrhosis or cancer. To date, liver biopsy remains the gold standard for assessing the severity of these diseases, but this invasive technique carries risks and limitations.<\/p>\n
A recent study shows that quantitative magnetic resonance imaging (MRI), or quantitative MRI, could offer a reliable alternative. This technology allows precise measurement of liver tissue characteristics without the need for surgery. Researchers analyzed data from 88 patients with metabolic-associated fatty liver disease, an abnormal accumulation of fat in the liver. Using advanced techniques such as MRI elastography, which assesses liver stiffness, or corrected T1 mapping, which measures tissue changes, they were able to identify different stages of the disease.<\/p>\n
The results reveal that certain quantitative MRI parameters, such as liver elasticity or stiffness, are closely linked to signs of severity, including inflammation and fibrosis. By combining these measurements with routine blood tests, such as liver enzyme levels, predictive models achieve remarkable accuracy. For example, the detection of advanced fibrosis, a key marker of progression to complications, showed efficacy comparable to that of non-invasive tests already used in clinical practice.<\/p>\n
One of the major advantages of this approach is its ability to reduce the need for biopsy, a procedure that can be painful and prone to sampling errors. Clinicians could thus monitor disease progression more simply and safely, adjusting treatments earlier and in a personalized manner.<\/p>\n
This advancement paves the way for less aggressive and more accessible management for the millions of people affected. It could also facilitate the monitoring of at-risk patients by enabling regular assessments without the drawbacks of an invasive procedure. The next steps will involve validating these results in larger populations to confirm their utility in routine practice.<\/p>\n
DOI:<\/strong> https:\/\/doi.org\/10.1007\/s00330-026-12451-5<\/a><\/p>\n Title:<\/strong> Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease<\/p>\n Journal:<\/strong> European Radiology<\/p>\n Publisher:<\/strong> Springer Science and Business Media LLC<\/p>\n Authors:<\/strong> Nienke P. M. Wassenaar; Koen C. van Son; Bas Voermans; Kirsi M. A. van Eekhout; Marian A. Troelstra; Stan Driessen; Anne Line Mak; Julia J. Witjes; Anne-Marieke van Dijk; Veera Houttu; Diona Zwirs; Elizabeth Shumbayawonda; Max Nieuwdorp; Michail Doukas; Joanne Verheij; Aart J. Nederveen; Oliver J. Gurney-Champion; Adriaan G. Holleboom<\/p>\n","protected":false},"excerpt":{"rendered":" Can Magnetic Resonance Imaging Replace Liver Biopsy for Detecting Metabolism-Related Liver Diseases? Metabolism-related liver diseases affect nearly one in three adults worldwide. These conditions, often associated with obesity or type 2 diabetes, can progress to serious complications such as cirrhosis or cancer. To date, liver biopsy remains the gold standard for assessing the severity of… Continue reading Can Magnetic Resonance Imaging Replace Liver Biopsy for Detecting Metabolism-Related Liver Diseases?<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,8],"tags":[],"class_list":["post-44","post","type-post","status-publish","format-standard","hentry","category-health","category-international","entry"],"_links":{"self":[{"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/posts\/44","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/comments?post=44"}],"version-history":[{"count":1,"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/posts\/44\/revisions"}],"predecessor-version":[{"id":45,"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/posts\/44\/revisions\/45"}],"wp:attachment":[{"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/media?parent=44"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/categories?post=44"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themedicaltribune.com\/en\/wp-json\/wp\/v2\/tags?post=44"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}